<DOC>
	<DOCNO>NCT00219011</DOCNO>
	<brief_summary>This study design determine patient , high blood pressure heart failure currently receive drug treatment heart failure , improvement heart failure sign symptom indicator heart failure treat aliskiren top current heart failure treatment . Aliskiren investigational drug ; safety also evaluate trial .</brief_summary>
	<brief_title>`` ALOFT - Aliskiren Observation Heart Failure Treatment '' : Efficacy Safety Aliskiren Added Top Standard Therapy Adults ( â‰¥ 18 Years ) With Stable Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>History diagnosis currently high blood pressure Stable heart failure ( NYHA Class 24 ) least 1 month study entry . Subject stable dose regimen heart failure medication . Brain natriuretic peptide ( BNP ) &gt; 150 pg/ml baseline ( evaluated physician first visit ) Previous treatment aliskiren High blood pressure due secondary reason constant low blood pressure ( systolic &lt; 90 mmHg ) History heart attack coronary bypass surgery past 6 month Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Aliskiren , heart failure , hypertension</keyword>
</DOC>